Christopher Richard Anzalone, CEO: Arrowhead Pharmaceuticals ARWR Planned sale · Filed 25/12/22

Trade details

Type: Planned sale notice
Stock: Arrowhead Pharmaceuticals ARWR
Person: Christopher Richard AnzaloneCEO
Planned sale date: 25/12/22
Filed: 25/12/22

More to sell after $18.7M in 3 months

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/22~01/21

Christopher Richard Anzalone's recent trades

Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$488.6K
7,416 sh
$488.6K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$383.1K
5,771 sh
$383.1K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$871.7K
13,187 sh
$871.7K
Filed 01/02
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$2.4M
35,181 sh
$2.4M
Filed 25/12/30
Traded 25/12/29
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$1.1M
16,545 sh
$1.1M
Filed 25/12/30
Traded 25/12/29

Christopher Richard Anzalone, CEO — plans to sell 12,586 sh of Arrowhead Pharmaceuticals ARWR · $861.3K · around 12/22 · 10b5-1 plan | Whalegun